MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Long-term quality of life after subthalamic deep brain stimulation depends on non-motor symptoms in Parkinson’s disease

    S. Jost, L. Timmermann, A. Rizos, M. Silverdale, J. Evans, P. Loehrer, M. Samuel, J. Petry-Schmelzer, A. Sauerbier, M. Barbe, G. Fink, V. Visser-Vandewalle, K. Ashkan, A. Antonini, P. Martinez-Martin, K. Ray Chaudhuri, H. Dafsari (Cologne, Germany)

    Objective: To predict 36-month follow-up quality of life (QoL) outcome after bilateral subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson’s disease (PD). Background: STN-DBS improves…
  • MDS Virtual Congress 2020

    Depression in Parkinson’s Disease: perspectives from an Australian cohort

    M. Lubomski, R. Davis, C. Sue (Sydney, Australia)

    Objective: This study aimed to identify clinical predictors and management implications for depression in an Australian cohort of Parkinson’s disease (PD) patients. Background: Depression is…
  • MDS Virtual Congress 2020

    Pain Syndromes in Parkinsonism Depending on the Form Disease

    N. Nurmuxamedova, R. Matmurodov, E. Abduqodirov (Tashkent, Uzbekistan)

    Objective: To study of pain syndromes in various forms of Parkinsonism. Background: Pain can occur in the premotor stage of Parkinson's disease, motor signs are…
  • MDS Virtual Congress 2020

    Prevalence of non-motor symptoms in Parkinson’s disease using the Movement Disorder Society-Non-Motor Rating Scale (MDS-NMS) and comparable scales

    C. Rodriguez-Blazquez, A. Schrag, D. Weintraub, A. Rizos, K.R Chaudhuri, P. Martinez-Martin (Madrid, Spain)

    Objective: To analyze the frequency and differences in distribution by sex and disease severity of non-motor symptoms (NMS) in patients with Parkinson’s disease (PD) using…
  • MDS Virtual Congress 2020

    Sexual dysfunction precedes the classical motor symptoms of Parkinson’s disease?

    T. Uchiyama, T. Yamamoto, R. Sakakibara, K. Suzuki, T. Kadowaki, S. Kuwabara, K. Hirata, H. Murai (Chiba, Japan)

    Objective: To investigate whether sexual dysfunction precedes the classical motor symptoms of Parkinson’s disease. Background: There is growing evidence that some symptoms can precede the…
  • MDS Virtual Congress 2020

    A Parkinson’s disease (PD) case with underlying cerebral small vessel disease (CSVD)

    L.X Cao, W. Dong, Y. Li, G. Du, J.H Yin, Q. Yang, Y.Q Zhang, B. Chen, Y. Huang (Beijing, China)

    Objective: Emphasis of CSVD in PD through clinical-pathological correlation study. Background: PD affects 1.7%, while CSVD affects about 45% [1], of the population aged over…
  • MDS Virtual Congress 2020

    Parkinson’s disease and osteocalcin pilot study: Is there a protective role of bone in neurodegeneration?

    A.S Nordvig, R.N Alcalay, J.M Berger, K. Marder, G. Karsenty, A. Wang (New York, NY, USA)

    Objective: To characterize the relationship between the bone-derived hormone osteocalcin (OCN) and Parkinson’s disease (PD) in humans, and explore sex and treatment differences. Background: The…
  • MDS Virtual Congress 2020

    Neuroimaging of anxiety in Parkinson’s disease: a systematic review

    G. Carey, M. Görmezoğlu, K. Dujardin, A. Leentjens (Maastricht, Netherlands)

    Objective: The aim of this systematic review was 1) to identify the brain regions involved in anxiety in Parkinson's disease (PD) based on neuroimaging studies,…
  • MDS Virtual Congress 2020

    Clinical and neurological features of the course of parkinsonism in the presence of chronic renal disease

    S. Khudayarova, G. Rakhmatullaeva (Tashkent, Uzbekistan)

    Objective: To study the clinical and neurological features of the course of parkinsonism in chronic renal disease. Background: Under our supervision were 30 patients with…
  • MDS Virtual Congress 2020

    IncobotulinumtoxinA to treat sialorrhea in Parkinson’s disease: A real-life study

    B. Bergmans, V. Schotte, N. Sys, E. Van Massenhove, M. Van Zandijcke (Brugge, Belgium)

    Objective: We evaluate the long-term efficacy and safety of incobotulinumtoxinA injections in advanced Parkinson’s disease (PD) patients suffering from sialorrhea (10 injection cycles into the…
  • « Previous Page
  • 1
  • …
  • 145
  • 146
  • 147
  • 148
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley